References

1. Cornell, H.J., Czyzewska, A., Macrae, F.A., Rydzewska, G., Nasierowska-Gutmejer, A., Bednarczuk, A., & Stelmasiak, T. (2016). The effect of enzyme supplementation on symptoms and duodenal histology in celiac patients. International Journal of Celiac Disease, 4, 40-47. 
2. Żebrowska, A., Cornell, H.J., Macrae, F.A., Sysa‐Jędrzejowska, A., Waszczykowska, E., & Stelmasiak, T. (2014). The Effect of Enzyme Therapy on Skin Symptoms and Immune Responses in Patients with Dermatitis Herpetiformis. International Journal of Celiac Disease, 2, 58-63. 
3. Tanner GJ (2021) Relative Rates of Gluten Digestion by Nine Commercial Dietary Digestive Supplements. Front. Nutr. 8:784850. doi: 10.3389/fnut.2021.784850.
4. Cornell HJ, Stelmasiak T. Caricain: A basis for enzyme therapy for coeliac disease. S Afr J Sci. 2011;107(9/10), Art.#529, 5 pages. doi:10.4102/sajs.v107i9/10.529.
5. What is Gluten? - Beyond Celiac. View here: https://www.beyondceliac.org/gluten-free-diet/what-is-gluten/ 
6. Celiac Disease Symptoms – Beyond Celiac. View here: https://www.beyondceliac.org/celiac-disease/symptoms/ 
7. Non-Celiac Gluten Sensitivity Symptoms - Beyond Celiac. View here:  https://www.beyondceliac.org/celiac-disease/non-celiac-gluten-sensitivity/ 
8. Celiac Disease - Canadian Digestive Health Foundation. View here: https://cdhf.ca/en/digestive-conditions/celiac-disease/
9. Silvester J, et al, ‘Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet’ (2016) 44 Alimentary Pharmacology and Therapeutics 612–619. 
10. IPSOS GluteGuard^® Concept Test.
11. Celiac Disease Foundation - iCureCeliac Patient Registry. View here: https://celiac.org/main/wp-content/uploads/2020/01/Celiac-Disease-Facts-and-Figures-FINAL-1.27.pdf 
12. Joelson et al 2018 - The Effect of Depressive Symptoms on the Association between Gluten-Free Diet Adherence and Symptoms in Celiac Disease: Analysis of a Patient Powered Research Network. Nutrients 2018, 10, 538.
13. GluteGuard^® Product License.